KalshiComprobar disponibilidadKYC requerido2% de comisiónDatos de resolución verificadosCalibración aceptableProbabilidad implícita actual
Before Jan 1, 2032 59%Líder entre 6 opciones
Calidad del mercado
47 / 100
Baja calidadVolumen 24h
81,9 €
Liquidez
5,7 mil €
Liquidez mediaSpread
5.0 pt
Spread moderadoDatos de mercado
Actualizado hace 10 minutos
14 may 26, 2:00 UTC1 ene 28, 4:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will the FDA approve cytisinicline for smoking cessation?
KalshiWill the FDA approve CagriSema?
KalshiWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any strain of influenza before 2028?
Manifold MarketsReglas
If the FDA approves midomafetamine / MDMA for PTSD for marketing the named outcome, then the market resolves to Yes.
Liquida mediante:Food and Drug Administration
- An approval is defined as:
- For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA (sNDA) or supplemental BLA (sBLA) for the specific indication referenced For generic drugs: FDA approval of an Abbreviated New Drug Application (ANDA) For biosimilars: FDA approval of a 351(k) application
- The following constitute approvals that trigger the Payout Criterion:
- Standard approval (traditional approval based on clinical benefit) Accelerated approval (based on surrogate endpoints) Approval with Risk Evaluation and Mitigation Strategy (REMS) Approval with restricted distribution or indication limitations, except compassionate use/expanded access programs
- The following do NOT constitute approvals:
Mercados abiertos
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Volumen total
- 15,7 M €
- Volumen 24h
- 52,2 mil €
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 resultados más
- Volumen total
- 870,4 mil €
- Volumen 24h
- 2,1 mil €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Volumen total
- 922,5 mil €
- Volumen 24h
- 1,8 mil €
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 resultados más
- Volumen total
- 32,4 mil €
- Volumen 24h
- 1,3 mil €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Volumen total
- 1,6 M €
- Volumen 24h
- 933,9 €
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 resultados más
- Volumen total
- 810,1 €
- Volumen 24h
- 767 €
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de Will the FDA approve MDMA for PTSD??
- Kalshi cotiza Before Jan 1, 2032 al 59% a fecha de 11 de septiembre de 2026.
- ¿Cuándo se resuelve Will the FDA approve MDMA for PTSD??
- Está previsto que Will the FDA approve MDMA for PTSD? se resuelva el 1 de enero de 2028.
- ¿Cómo se liquida Will the FDA approve MDMA for PTSD??
- Kalshi liquida este mercado del siguiente modo: If the FDA approves midomafetamine / MDMA for PTSD for marketing the named outcome, then the market resolves to Yes.